Table of Content

1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Technology
2.5. Snippet by Testing Type
2.6. Snippet by Application
2.7. Snippet by Region
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Increasing Prevalence of Genetic Disorders and Chronic Diseases
3.1.1.2. Advances In Next-Generation Sequencing (NGS) and PCR Technologies
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. High Cost of Genetic Tests and Sequencing Technologies
3.1.2.2. Ethical and Privacy Concerns Regarding Genetic Data
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Emerging Markets with Untapped Growth Potential
3.1.3.2. XX
3.1.4. Impact Analysis
4. Strategic Insights and Industry Outlook
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with the largest-selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. Regulatory and Reimbursement Landscape
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. South America
4.5.5. Middle East & Africa
4.6. Porter’s Five Forces Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders
5. Genetic Testing Market, By Product Type
5.1. Introduction
5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index By Product Type
5.2. Consumables*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Equipment
5.4. Software
6. Genetic Testing Market, By Technology
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
6.1.2. Market Attractiveness Index By Technology
6.2. Next-Generation Sequencing (NGS)*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Polymerase Chain Reaction (PCR)
6.4. Fluorescence in Situ Hybridization (FISH Test)
6.5. Others
7. Genetic Testing Market, By Testing Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
7.1.2. Market Attractiveness Index By Testing Type
7.2. Carrier Testing*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Prenatal and Newborn Testing
7.4. Preimplantation Testing
7.5. Predictive and presymptomatic testing
7.6. Forensic testing
7.7. Diagnostic Testing
7.8. Others
8. Genetic Testing Market, By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Cancer Diagnosis*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Genetic Disease Diagnosis
8.4. Cardiovascular Disease Diagnosis
8.5. Others
9. Genetic Testing Market, By Regional Market Analysis and Growth Opportunities
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. U.K.
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. Brazil
9.4.7.2. Argentina
9.4.7.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. China
9.5.7.2. India
9.5.7.3. Japan
9.5.7.4. South Korea
9.5.7.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Type
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10. Competitive Landscape and Market Positioning
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. Company Profiles
11.1.1. Abbott Laboratories*
11.1.2. Company Overview
11.1.3. Product Portfolio
11.1.3.1. Product Description
11.1.3.2. Product Key Performance Indicators (KPIs)
11.1.3.3. Historic and Forecasted Product Sales
11.1.3.4. Product Sales Volume
11.1.4. Financial Overview
11.1.4.1. Company Revenue
11.1.4.2. Geographical Revenue Shares
11.1.4.3. Revenue Forecasts
11.1.5. Key Developments
11.1.5.1. Mergers & Acquisitions
11.1.5.2. Key Product Development Activities
11.1.5.3. Regulatory Approvals, etc.
11.1.6. SWOT Analysis
11.2. BioRad Laboratories Inc
11.3. Illumina Inc
11.4. Myriad Genetics Inc
11.5. Danaher Corporation
11.6. Quest Diagnostics Incorporated
11.7. MedGenome
11.8. LabCorp
11.9. 3billion, Inc
11.10. Blueprint Genetics
LIST NOT EXHAUSTIVE
12. Assumptions and Research Methodology
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. Appendix
13.1. About Us and Services
13.2. Contact Us